Leadership Overview
Bloodworks Northwest has 4 executives leading key functions including strategy, finance, information technology, and human resources.
Dedicated to advancing community health, Bloodworks Northwest operates as a vital non-profit blood donation organization, ensuring a consistent and safe blood supply for hospitals across the Northwest region through rigorous collection, testing, and distribution processes.
Dedicated to advancing community health, Bloodworks Northwest operates as a vital non-profit blood donation organization, ensuring a consistent and safe blood supply for hospitals across the Northwest region through rigorous collection, testing, and distribution processes.
Leadership Roles at Bloodworks Northwest
Brandon Ford - Chief Executive Officer
Brandon Ford, the Chief Executive Officer at Bloodworks Northwest, directs the organization's overarching strategy and operational execution. Ford guides the non-profit's mission to collect, test, and distribute blood products to hospitals throughout the Northwest region. This leadership role involves fostering key relationships with healthcare providers and community stakeholders to ensure a stable and sufficient blood supply. Ford's strategic vision drives initiatives aimed at increasing donor engagement and operational efficiency. Overseeing all major organizational functions, Brandon Ford ensures alignment with the core objectives of serving community health needs and maintaining the highest standards of safety and efficacy in blood services. The Chief Executive Officer's responsibilities extend to long-term planning and resource allocation, positioning Bloodworks Northwest for sustained impact and growth in its critical service area.
Robert Gleason - Chief Financial Officer
Robert Gleason, the Chief Financial Officer at Bloodworks Northwest, manages all financial operations and fiscal strategy. Gleason oversees budgeting, financial planning, and reporting, ensuring the organization's financial health and sustainability. This role is critical for allocating resources effectively to support Bloodworks Northwest's mission of collecting, testing, and distributing blood to hospitals across the Northwest. The Chief Financial Officer directs financial controls and risk management processes, safeguarding the organization's assets and ensuring compliance with all relevant regulations. Gleason's expertise supports strategic decision-making by providing accurate financial insights and forecasts. By optimizing financial performance, Robert Gleason enables Bloodworks Northwest to expand its reach and enhance its services to the community. This leadership position involves close collaboration with other executives to align financial goals with operational objectives.
Joseph Vetto - Chief Information Officer
Joseph Vetto, the Chief Information Officer at Bloodworks Northwest, leads the organization's technology strategy and infrastructure. Vetto oversees the development and implementation of information systems that support Bloodworks Northwest's core operations, including blood collection, testing, and distribution to hospitals throughout the Northwest. This critical role ensures the integrity, security, and efficiency of all technological resources. The Chief Information Officer drives innovation in IT solutions, enhancing data management and operational workflows. Vetto's responsibilities include managing cybersecurity measures and ensuring compliance with data privacy regulations. By leveraging technology, Joseph Vetto strengthens the organization's capacity to serve the community effectively and reliably. This leadership position involves collaborating with departments to identify technological needs and implement solutions that advance the mission.
Anne Sauget - Chief Human Resources Officer
Anne Sauget, the Chief Human Resources Officer at Bloodworks Northwest, directs all human capital strategies and initiatives. Sauget oversees talent acquisition, employee relations, compensation, benefits, and organizational development to support Bloodworks Northwest's mission of providing essential blood services. This role is pivotal in cultivating a skilled and engaged workforce dedicated to the organization's goals of collecting, testing, and distributing blood to hospitals across the Northwest. The Chief Human Resources Officer ensures a positive and productive work environment, fostering a culture of collaboration and commitment. Sauget's leadership focuses on attracting and retaining top talent, essential for maintaining high operational standards. By championing employee well-being and professional growth, Anne Sauget contributes significantly to the overall success and mission fulfillment of Bloodworks Northwest.
Explore Leadership Teams in Blood & Organ Banks
Carter BloodCare is an independent, community blood center providing transfusion resources. Services include collection, processing, specialized laboratory testing, storage and distribution of blood and blood products. The program is accredited by the AABB, including a laboratory with accreditation for molecular testing of red cell antigens. It is licensed by the U.S. Food and Drug Administration and is a member of America's Blood Centers.
Company Leadership SP
VM
NJ
BG
OneBlood, headquartered in Orlando, Florida, is a non-profit organization that specializes in blood donation for hospitals.
Company Leadership GS
CN
VC
SP
Founded in 1987 and headquartered in Edison, New Jersey, MTF Biologics is a tissue bank that offers allograft tissue transplant services, orthopedics, wound care, reconstructive surgery, and more.
Company Leadership FE
MK
DA
MS
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Vivotif vaccine for oral administration for the prevention of typhoid fever; Anthrasil for the treatment of inhalational anthrax; BioThrax, an anthrax vaccine; CYFENDUS for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; and Raxibacumab injection for the treatment and prophylaxis of inhalational anthrax. It also provides ACAM2000, a smallpox vaccine; CNJ-016 to address complications from smallpox vaccination; TEMBEXA for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; BAT for the treatment of symptomatic botulism; Ebanga for the treatment of Ebola; Reactive Skin Decontamination Lotion Kit to remove or neutralize chemical warfare agents from the skin; Trobigard, a atropine sulfate obidoxime chloride auto-injector. In addition, the company is developing CGRD-001 for the treatment of poisoning by organophosphorus nerve agents or organophosphorus compounds; EBS-LASV to prevent Lassa fever; EBS-MARV to prevent Marburg virus disease; EBS-SUDV to prevent Sudan virus disease; Pan-Ebola mAbs for the treatment of ebola virus; SIAN Antidote for initial treatment of certain or suspected acute cyanide poisoning; UniFlu for immunity against influenza A and B viruses; and WEVEE-VLP for equine encephalitis virus infections. Further, it provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.
Company Leadership MP
HA
KL
SL